Variant report
Variant | nsv460742 |
---|---|
Chromosome Location | chr3:83852918-83907751 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578036867 | chr3:83862025-83862026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112319235 | chr3:83862032-83862033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182301448 | chr3:83862070-83862071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551340123 | chr3:83862081-83862082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375317720 | chr3:83862093-83862094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557097453 | chr3:83862122-83862123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548692108 | chr3:83862155-83862156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113940908 | chr3:83862159-83862160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187410942 | chr3:83862185-83862186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368947865 | chr3:83862186-83862187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556852013 | chr3:83870206-83870207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540093358 | chr3:83870217-83870218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111647847 | chr3:83870275-83870276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558417110 | chr3:83870281-83870282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576771906 | chr3:83870293-83870294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115077844 | chr3:83870306-83870307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562918221 | chr3:83870320-83870321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111998086 | chr3:83870390-83870391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185335006 | chr3:83870435-83870436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542314668 | chr3:83870482-83870483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560630051 | chr3:83870500-83870501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527879706 | chr3:83870516-83870517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552850561 | chr3:83870567-83870568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535954777 | chr3:83876415-83876416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528946006 | chr3:83876472-83876473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560165487 | chr3:83876505-83876506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547950817 | chr3:83876521-83876522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145335176 | chr3:83876540-83876541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149199748 | chr3:83876551-83876552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143079098 | chr3:83876567-83876568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558804225 | chr3:83876574-83876575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548772947 | chr3:83876660-83876661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138769194 | chr3:83876670-83876671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538223135 | chr3:83876717-83876718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113207458 | chr3:83876745-83876746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372174068 | chr3:83876771-83876772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574959059 | chr3:83876774-83876775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542346385 | chr3:83876775-83876776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560630035 | chr3:83876786-83876787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572669657 | chr3:83876813-83876814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368173812 | chr3:83876830-83876831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74525755 | chr3:83876850-83876851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564781658 | chr3:83876957-83876958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77128725 | chr3:83881208-83881209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13059952 | chr3:83881213-83881214 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs573589757 | chr3:83881223-83881224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549798442 | chr3:83881282-83881283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374352143 | chr3:83881478-83881479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554500623 | chr3:83881544-83881545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190437743 | chr3:83881555-83881556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83862000-83862200 | Enhancers | Spleen | Spleen |
2 | chr3:83870200-83870600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr3:83876400-83877000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr3:83881200-83883400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr3:83883400-83883800 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr3:83883800-83897800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr3:83884400-83885000 | Active TSS | Gastric | stomach |
8 | chr3:83892800-83893200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr3:83898400-83899000 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr3:83898600-83900000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:83900000-83900800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:83900800-83902400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |